Editing Respinor

{{DISPLAYTITLE:Respinor}}
{{Infobox company
| name = Respinor AS
| org_number = 915417310
| founded = 2015-04-15
| employees = 9
| address = Norway
| industry = 72.100 – Biotechnology research
| website = https://respinor.com
| nht_category = Startup
| description = Respinor develops DXT — a novel non-invasive ultrasound-based medical device for accurate and continuous diaphragm monitoring. Enables early detection of diaphragm dysfunction in critical care settings. Successfully validated in clinical studies on mechanically ventilated patients.
| notes = 9 employees. Successfully validated in clinical studies. Diaphragm dysfunction in ICU is a significant unmet need — affects ICU mortality and weaning outcomes.
| related_companies = [[Cimon Medical]], [[ODI Medical]], [[GlucoSet]], [[Mode Sensors]], [[Norway Health Tech]]
| categories = Norway Health Tech, Startups, Medical Devices, Intensive Care, Diagnostics, Respiratory
| sources = https://respinor.com; https://data.brreg.no/enhetsregisteret/api/enheter/915417310
}}

== About ==

Respinor AS is a Norwegian medical technology company developing non-invasive ultrasound-based monitoring solutions for diaphragm function. Founded in 2015 with 9 employees.

== Product ==

=== DXT ===

DXT is a novel, non-invasive ultrasound device for diaphragm monitoring. Key features:

* Non-invasive ultrasound-based technology
* Accurate and continuous diaphragm monitoring
* Enables early detection of diaphragm dysfunction
* Designed for critical care settings
* Successfully validated in clinical studies on mechanically ventilated patients

== Clinical Need ==

Diaphragm dysfunction in critically ill patients is associated with:
* Increased mortality in ICU
* Prolonged mechanical ventilation
* Difficult weaning from ventilators
* Increased healthcare costs

Currently, monitoring diaphragm function in ICU patients is challenging. DXT addresses this with a non-invasive approach that can detect dysfunction early.

== Market ==

Critical care monitoring represents a significant market. Diaphragm ultrasound is an emerging standard of care, and a dedicated device for continuous monitoring could address a growing clinical need as ICU awareness of diaphragm dysfunction increases.

== References ==
<references/>

[[Category:Norway Health Tech]]
[[Category:Startups]]
[[Category:Medical Devices]]
[[Category:Intensive Care]]
[[Category:Diagnostics]]
[[Category:Respiratory]]